drugset / Trial / NCT06579300

A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

NCT06579300 ↗

Phase 1 Terminated 72 enrolled AbbVie
RandomizedParallel-groupTriple-blindBasic science

Summary

This study will assess the safety, tolerability, and pharmacokinetics of ABBV-1088 in healthy adult Western, Han-Chinese and Japanese participants. This study will also assess drug-drug interaction between itraconazole and ABBV-1088 in healthy adult Western participants.

Timeline

Start
2024-09-04
Primary completion
2025-09-03
Completion
2025-09-03

Outcome

Outcome not reported

Stopped (Business): “Strategic considerations”

Drugs

EvaluationDrugModalityDoseRoute
Subject ABBV-1088 Unknown — Oral
Subject Itraconazole Small molecule — Oral

Indications

No indication recorded.